Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology | Family Medicine
Disease Category: Acne
Location: United States, FL

Clinical Trial Details

Overview

Research Study Summary

Facial Acne Study for Men or Women Ages 12 to 65. Compensation for time and travel may be up to $200.00

Purpose

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo Israel Pharmaceuticals, Ltd., Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to BenzaClin Topical Gel (Clindamycin-Benzoyl Peroxide Gel) and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris

Patient Inclusion Criteria:

  • Age 12 to 65
  • Mild to Moderate Facial Acne
  • Willing to stop current acne treatment
  • Willing to complete 4 Office Visits with in 12 Weeks as required by the study

Patient Exclusion Criteria:

  • Severe Facial Acne
  • Facial Hair Present at the time of Screening Appointment
  • Not Willing to discontinue current Acne Treatment while in the trial

To Learn more
Phase

3

Gender

Both Male and Female

Age

12 to 65 Years

Overall Status

Recruiting

Duration

12 Weeks

Facility Type

N/A

Compensation

Up to $200

Contact

Diana, Patient Recruiter
University Clinical Research, Inc.
1150 N University Drive
Pembroke Pines, FL 33024
Phone: 954-437-5988
Fax: 954-431-0007

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 162799

Date Last Changed: July 24, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.